LUCIER GREGORY T 4/A

What Happened

• Gregory T. Lucier, a director of Maravai LifeSciences Holdings, Inc. (MRVI), was awarded 46,293 restricted stock units (RSUs) on May 26, 2026. The grant is reported as an award/acquisition (code A) at $0.00 per share (total reported value $0).
• The grant was reported on a Form 4 filed May 28, 2026 and this filing was amended to correct the previously reported purchase price.

Key Details

• Transaction date: May 26, 2026; Form 4 filed May 28, 2026 (amended filing).
• Award: 46,293 RSUs; reported acquisition price: $0.00 per share.
• Vesting: RSUs vest in full upon the earlier of one year from the grant date or the date of the 2027 Maravai annual meeting (footnote F1).
• Shares owned after the transaction: not disclosed in the Form 4 provided.
• Footnote F2: This Form 4 amends an earlier filing on the same date to correct the reported purchase price.

Context

• RSUs are a non-cash equity award that convert into shares if and when they vest; this is a grant/compensation event (not an open-market purchase or sale).
• Such awards are commonly used for retention or compensation of directors and do not by themselves indicate immediate buying or selling for liquidity.